Discussion Venous thromboembolism (VTE), the collective term for DVT and pulmonary
embolism, is a relatively common disorder, with an incidence of about one to two cases per …

The incidence of pediatric venous thromboembolism (VTE) has been increasing in the past
few decades and can be associated with significant mortality and morbidity. There are …

Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy.
However, data show an improvement in the quality of life for transgender people who use …

Background: Venous thromboembolism (VTE) is a rare side effect of hormonal therapy in
transgender persons. Prothrombotic genetic variants can increase this risk. For this reason …

Introduction One of the most serious known adverse effects of feminizing cross-sex hormone
therapy (CSHT) is venous thromboembolism (VTE); however, no study has assessed the …

Venous thromboembolism can be precipitated by both genetic and acquired factors, but the
role of testosterone therapy is less clear. Here, we present a 17-year-old transgender …

The medical care of transgender patients relies on the use of sex hormones to develop and
maintain the physical characteristics consistent with gender identity as the first step in …

Gender dysphoria refers to psychological distress that results from an incongruence
between gender identity and sex assigned at birth. Administration of sex hormones is most …

Objective We present the case of a male-to-female transsexual person in her 20s requesting
hormone therapy in the setting of a history of a deep venous thrombosis and pulmonary …

Gender-affirming therapy involves the use of hormones to develop the physical
characteristics of the identified gender and suppressing endogenous sex hormone …